ResearcherMaastricht UniversityActive in the last 2 years

A.J. de Wilde

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2389-1171; OpenAlex author ID A5082930513, A5127839815. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2026: 2 papers

Papers 2

Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancer. Co-author DOI 10.1016/j.esmogo.2026.100311 ↗
Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial. Last author DOI 10.1200/jco-25-01935 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ruth A.L. Willems · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Johanna W. Wilmink · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Merlijn U.J.E. Graus · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Stefan A.W. Bouwense · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Judith de Vos‐Geelen · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Ignace H. J. T. de Hingh · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
N C Biesma · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Hjalmar C. van Santvoort · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗
Marjolein Y.V. Homs · 1 shared paper, 2026 · strength 0.24
- Paper Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemothera… DOI 10.1016/j.esmogo.2026.100311 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.